Literature DB >> 23365169

Paradoxical response to dexamethasone and spontaneous hypocortisolism in Cushing's disease.

Anurag R Lila1, Vijaya Sarathi, Tushar R Bandgar, Nalini S Shah.   

Abstract

Paradoxical response to dexamethasone and spontaneous development of hypocortisolism are rare features of Cushing's disease. We report a 13-year-old boy with Cushing's disease owing to a pituitary macroadenoma. On initial evaluation, he had partial suppression of serum cortisol by dexamethasone. He developed transient hypocortisolism after first adenomectomy, but the disease recurred after 1 year. Repeat evaluation showed recurrent hypercortisolism and paradoxical response to dexamethasone. He underwent second surgery and, postoperatively, hypercostisolism persisted even after 2 years of surgery. Repeat evaluations after 8 years of second surgery revealed persistent hypocortisolism despite residual tumour of same size and similar plasma adrenocorticotropic hormone (ACTH) levels. We have also shown that the paradoxical increase in serum cortisol was preceded by a paradoxical increase in ACTH. The paradoxical response persisted despite hypocortisolism. This patient with Cushing's disease had two very rare features: paradoxical response to dexamethasone and spontaneous development of hypocortisolism.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23365169      PMCID: PMC3604017          DOI: 10.1136/bcr-2012-008035

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  10 in total

1.  A pituitary adenoma secreting high molecular weight adrenocorticotropin without evidence of Cushing's disease.

Authors:  M Reincke; B Allolio; W Saeger; D Kaulen; W Winkelmann
Journal:  J Clin Endocrinol Metab       Date:  1987-12       Impact factor: 5.958

2.  Variable hormonogenesis in Cushing's syndrome.

Authors:  M S Shapiro; L Shenkman
Journal:  Q J Med       Date:  1991-04

3.  Paradoxical ACTH response to glucocorticoids in Cushing's disease.

Authors:  H L Fehm; K H Voight; R E Lang; K E Beinert; G W Kummer; E F Pfeiffer
Journal:  N Engl J Med       Date:  1977-10-27       Impact factor: 91.245

4.  Corticotrophic macroadenoma of the pituitary associated with hypoadrenalism.

Authors:  I Peacock; W J Jeffcoate
Journal:  Clin Endocrinol (Oxf)       Date:  1997-06       Impact factor: 3.478

5.  Cushing's disease with periodic hormonogenesis: one explanation for paradoxical response to dexamethasone.

Authors:  R D Brown; G R Van Loon; D N Orth; G W Liddle
Journal:  J Clin Endocrinol Metab       Date:  1973-03       Impact factor: 5.958

6.  Cyclic Cushing's disease with paradoxical response to dexamethasone.

Authors:  S Checchi; L Brilli; E Guarino; C Ciuoli; G Di Cairano; P Mazzucato; F Pacini
Journal:  J Endocrinol Invest       Date:  2005-09       Impact factor: 4.256

7.  Paradoxical response to dexamethasone in the diagnosis of primary pigmented nodular adrenocortical disease.

Authors:  C A Stratakis; N Sarlis; L S Kirschner; J A Carney; J L Doppman; L K Nieman; G P Chrousos; D A Papanicolaou
Journal:  Ann Intern Med       Date:  1999-10-19       Impact factor: 25.391

8.  The prevalence and characteristic features of cyclicity and variability in Cushing's disease.

Authors:  Krystallenia I Alexandraki; Gregory A Kaltsas; Andrea M Isidori; Scott A Akker; William M Drake; Shern L Chew; John P Monson; G Michael Besser; Ashley B Grossman
Journal:  Eur J Endocrinol       Date:  2009-03-16       Impact factor: 6.664

9.  Pheochromocytoma expressing adrenocorticotropin and corticotropin-releasing hormone; regulation by glucocorticoids and nerve growth factor.

Authors:  J Liu; P Heikkilä; R Voutilainen; S L Karonen; A I Kahri
Journal:  Eur J Endocrinol       Date:  1994-09       Impact factor: 6.664

10.  Impaired processing of proopiomelanocortin in corticotroph macroadenomas.

Authors:  S Gibson; D W Ray; S R Crosby; T L Dornan; A M Jennings; J S Bevan; J R Davis; A White
Journal:  J Clin Endocrinol Metab       Date:  1996-02       Impact factor: 5.958

  10 in total
  1 in total

1.  The changing faces of corticotroph cell adenomas: the role of prohormone convertase 1/3.

Authors:  Alberto Righi; Marco Faustini-Fustini; Luca Morandi; Valentina Monti; Sofia Asioli; Diego Mazzatenta; Antonella Bacci; Maria Pia Foschini
Journal:  Endocrine       Date:  2016-08-04       Impact factor: 3.633

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.